Cell competition and cancer from Drosophila to mammals

Throughout an individual’s life, somatic cells acquire cancer-associated mutations. A fraction of these mutations trigger tumour formation, a phenomenon partly driven by the interplay of mutant and wild-type cell clones competing for dominance; conversely, other mutations function against tumour initiation. This mechanism of ‘cell competition’, can shift clone dynamics by evaluating the relative status of clonal populations, promoting ‘winners’ and eliminating ‘losers’. This review examines the role of cell competition in the context of tumorigenesis, tumour progression and therapeutic intervention

Colon cancer cells evade drug action by enhancing drug metabolism [pre-print]

Colorectal cancer (CRC) is the second most deadly cancer worldwide. One key reason is the failure of therapies that target RAS proteins, which represent approximately 40% of CRC cases. Despite the recent discovery of multiple alternative signalling pathways that contribute to resistance, durable therapies remain an unmet need. Here, we use liquid chromatography/mass spectrometry (LC/MS) analyses on CRC tumour models to identify multiple metabolites in the glucuronidation pathway-a toxin clearance pathway-as upregulated in trametinib-resistant (" ") tumours compared to trametinib-sensitive tumours. Elevating glucuronidation was sufficient to direct trametinib resistance in animals while, conversely, inhibiting different steps along the glucuronidation pathway strongly reversed resistance to trametinib. For example, blocking an initial HDAC1-mediated deacetylation step with the FDA-approved drug vorinostat strongly suppressed trametinib resistance in tumours. We provide functional evidence that pairing oncogenic RAS with hyperactive WNT activity strongly elevates PI3K/AKT/GLUT signalling, which in turn directs elevated glucose and subsequent glucuronidation. Finally, we show that this mechanism of trametinib resistance is conserved in an mouse CRC tumour organoid model. Our observations demonstrate a key mechanism by which oncogenic RAS/WNT activity promotes increased drug clearance in CRC. The majority of targeted therapies are glucuronidated, and our results provide a specific path towards abrogating this resistance in clinical trials

WNT signalling promotes NF-κB activation and drug resistance in KRAS-mutant colorectal cancer [pre-print]

Approximately 40% of colorectal cancer (CRC) cases are characterized by KRAS mutations, rendering them insensitive to most CRC therapies. While the reasons for this resistance remain incompletely understood, one key aspect is genetic complexity: in CRC, oncogenic KRAS is most commonly paired with mutations that alter WNT and P53 activities ("RAP"). Here, we demonstrate that elevated WNT activity upregulates canonical (NF-κB) signalling in both and human RAS mutant tumours. This upregulation required Toll-1 and Toll-9 and resulted in reduced efficacy of RAS pathway targeted drugs such as the MEK inhibitor trametinib. Inhibiting WNT activity pharmacologically significantly suppressed trametinib resistance in RAP tumours and more genetically complex RAP-containing 'patient avatar' models. WNT/MEK drug inhibitor combinations were further improved by targeting brm, shg, ago rhoGAPp190 and upf1, highlighting these genes as candidate biomarkers for patients sensitive to this duel approach. These findings shed light on how genetic complexity impacts drug resistance and proposes a therapeutic strategy to reverse this resistance

Healthy cities initiative in China: Progress, challenges, and the way forward

Article discusses how China implemented the first phase of its National Healthy Cities pilot program from 2016-20. Authors recommend aligning the Healthy Cities initiative in China with strategic national and global level agendas such as Healthy China 2030 and the Sustainable Development Goals (SDGs) by providing an integrative governance framework to facilitate a coherent intersectoral program to systemically improve population health

JNK and Yorkie drive tumor progression by generating polyploid giant cells in Drosophila

Epithelial cancer tissues often possess polyploid giant cells, which are thought to be highly oncogenic. However, the mechanisms by which polyploid giant cells are generated in tumor tissues and how such cells contribute to tumor progression remain elusive. We previously noticed in Drosophila imaginal epithelium that cells mutant for the endocytic gene rab5 exhibit enlarged nuclei. Here we find that mutations in endocytic ‘neoplastic tumor-suppressor’ genes, such as rab5, vps25, erupted, or avalanche result in generation of polyploid giant cells. Genetic analyses on rab5-defective cells reveal that cooperative activation of JNK and Yorkie generates polyploid giant cells via endoreplication. Mechanistically, Yorkie-mediated upregulation of Diap1 cooperates with JNK to downregulate the G2/M cyclin CycB, thereby inducing endoreplication. Interestingly, malignant tumors induced by Ras activation and cell polarity defect also consist of polyploid giant cells, which are generated by JNK and Yorkie-mediated downregulation of CycB. Strikingly, elimination of polyploid giant cells from such malignant tumors by blocking endoreplication strongly suppressed tumor growth and metastatic behavior. Our observations suggest that JNK and Yorkie, two oncogenic proteins activated in many types of human cancers, cooperatively drive tumor progression by generating oncogenic polyploid giant cells

JNK and Yorkie drive tumor malignancy by inducing L-amino acid transporter 1 in Drosophila

Identifying a common oncogenesis pathway among tumors with different oncogenic mutations is critical for developing anti-cancer strategies. Here, we performed transcriptome analyses on two different models of Drosophila malignant tumors caused by Ras activation with cell polarity defects (RasV12/scrib-/-) or by microRNA bantam overexpression with endocytic defects (bantam/rab5-/-), followed by an RNAi screen for genes commonly essential for tumor growth and malignancy. We identified that Juvenile hormone Inducible-21 (JhI-21), a Drosophila homolog of the L-amino acid transporter 1 (LAT1), is upregulated in these malignant tumors with different oncogenic mutations and knocking down of JhI-21 strongly blocked their growth and invasion. JhI-21 expression was induced by simultaneous activation of c-Jun N-terminal kinase (JNK) and Yorkie (Yki) in these tumors and thereby contributed to tumor growth and progression by activating the mTOR-S6 pathway. Pharmacological inhibition of LAT1 activity in Drosophila larvae significantly suppressed growth of RasV12/scrib-/- tumors. Intriguingly, LAT1 inhibitory drugs did not suppress growth of bantam/rab5-/- tumors and overexpression of bantam rendered RasV12/scrib-/- tumors unresponsive to LAT1 inhibitors. Further analyses with RNA sequencing of bantam-expressing clones followed by an RNAi screen suggested that bantam induces drug resistance against LAT1 inhibitors via downregulation of the TMEM135-like gene CG31157. Our observations unveil an evolutionarily conserved role of LAT1 induction in driving Drosophila tumor malignancy and provide a powerful genetic model for studying cancer progression and drug resistance

JNK and Yorkie drive tumor malignancy by inducing L-amino acid transporter 1 in Drosophila

Identifying a common oncogenesis pathway among tumors with different oncogenic mutations is critical for developing anti-cancer strategies. Here, we performed transcriptome analyses on two different models of Drosophila malignant tumors caused by Ras activation with cell polarity defects (RasV12/scrib-/-) or by microRNA bantam overexpression with endocytic defects (bantam/rab5-/-), followed by an RNAi screen for genes commonly essential for tumor growth and malignancy. We identified that Juvenile hormone Inducible-21 (JhI-21), a Drosophila homolog of the L-amino acid transporter 1 (LAT1), is upregulated in these malignant tumors with different oncogenic mutations and knocking down of JhI-21 strongly blocked their growth and invasion. JhI-21 expression was induced by simultaneous activation of c-Jun N-terminal kinase (JNK) and Yorkie (Yki) in these tumors and thereby contributed to tumor growth and progression by activating the mTOR-S6 pathway. Pharmacological inhibition of LAT1 activity in Drosophila larvae significantly suppressed growth of RasV12/scrib-/- tumors. Intriguingly, LAT1 inhibitory drugs did not suppress growth of bantam/rab5-/- tumors and overexpression of bantam rendered RasV12/scrib-/- tumors unresponsive to LAT1 inhibitors. Further analyses with RNA sequencing of bantam-expressing clones followed by an RNAi screen suggested that bantam induces drug resistance against LAT1 inhibitors via downregulation of the TMEM135-like gene CG31157. Our observations unveil an evolutionarily conserved role of LAT1 induction in driving Drosophila tumor malignancy and provide a powerful genetic model for studying cancer progression and drug resistance

Data from: Reducing soil erosion by improving community functional diversity in semi-arid grasslands

1. Great efforts have been made to control soil erosion by restoring plant communities in degraded ecosystems world-wide. However, soil erosion has not been substantially reduced mainly because current restoration strategies lead to large areas of mono-specific vegetation, which are inefficient in reducing soil erosion because of their simple canopy and root structure. Therefore, an advanced understanding of how community functional composition affects soil erosion processes, as well as an improved restoration scheme to reduce soil erosion, is urgently needed. 2. We investigated the effect of community functional composition on soil erosion in restored semi-arid grasslands on the Loess Plateau of China. Community functional composition of 16 restored grasslands was quantified by community-weighted mean (CWM) and functional diversity (FD) trait values, which were calculated from nine plant functional traits of thirteen locally dominant plant species. Species richness and evenness were also measured. Soil erosion rates were measured using standard erosion plots. The multimodel inference approach was used to estimate the direction and the relative importance of these biodiversity indices in reducing soil erosion. 3. A robust and strong negative effect of functional divergence (FDiv) on soil erosion was found. The prevalence of particular trait combinations can also decrease soil erosion. The greatest control over soil erosion was exerted when the community mean root diameter was small and the root tensile strength was great. 4. Synthesis and applications: These findings imply that community functional diversity plays an important role in reducing soil erosion in semi-arid restored grasslands. This means that current restoration strategies can be greatly improved by incorporating community functional diversity into restoration design. We propose a trait-based restoration framework for reducing soil erosion, termed ‘SSM’ (Screening–Simulating–Maintaining). SSM aims to translate the target of community functional diversity into community assemblages that can be manipulated by practitioners. Based on this framework, a comprehensive procedure, highlighting functional diversity as the primary concern in determining optimal community assemblages, was developed to meet the pressing need for more effective restoration strategies to reduce soil erosion

Structure Disentanglement and Effect Analysis of the Arid Riverscape Social-Ecological System Using a Network Approach

Riverscapes are coupled social-ecological systems (SESs), in which the differences between the scales and functioning of interacting social and ecological components ( “mismatch”) impose challenges for global arid basin sustainability. Here, we defined riverscape SESs as networks of connected ecological and social components (nodes) to disentangle the structure and effects of SESs in Heihe River Basin (HRB) in arid regions of northwest China. Results showed the ecological network in HRB has low network density and high vertex strength. Heihe River Basin Bureau, as an emerging bridging organization, changed the SES structure and increased the matching degree of SES from 0.33 to 0.53, which has caused an obvious improvement in the downstream ecology. However, the characteristics of the ecological network demonstrated that cross-boundary management actions restricted to only the river would exacerbate local environmental pressures, such as the continued decline of groundwater in midstream regions and the potential appropriation of water for ecology by the expanding farmland in the downstream region. Our study demonstrated that network analysis could be one promising direction to untangle the complex SES and understand the relationship between SES structure and outcomes. We suggest comanaging the cross-boundary river and lands to further match the SES for basin sustainability.Arts and Sciences, Irving K. Barber School of (Okanagan)Non UBCEarth, Environmental and Geographic Sciences, Department of (Okanagan)ReviewedFacult